Hyperphosphatemia in children receiving peritoneal dialysis--an educational program

Area of Science:

• Nephrology
• Endocrinology
• Public Health

Background:

• Hyperphosphatemia is linked to severe health issues, including secondary hyperparathyroidism, renal osteodystrophy, and cardiovascular calcification.
• Effective management of hyperphosphatemia is crucial for improving patient outcomes and reducing mortality risk.

Purpose of the Study:

• To assess the impact of a 3-month educational intervention on serum phosphorus, calcium, parathyroid hormone (PTH), and patient knowledge.
• To determine if enhanced patient understanding of dietary phosphorus and phosphate binder management can improve clinical markers.

Main Methods:

• A one-group, pretest-posttest study design was employed.
• Evaluated serum phosphorus, calcium, calcium-phosphorus product, and PTH levels at pretreatment, during treatment, and posttreatment.
• Assessed patient knowledge through testing before and after the educational intervention.

Main Results:

• No significant changes were observed in mean serum phosphorus, calcium, calcium-phosphorus product, or PTH levels throughout the study.
• Patient test scores regarding dietary phosphorus and phosphate binder management remained unchanged.
• Despite the educational program, key biochemical markers frequently remained outside K/DOQI target guidelines.

Conclusions:

• A 3-month patient education program focusing on dietary phosphorus, phosphate binders, and compliance had no significant effect on biochemical parameters or patient knowledge.
• Current educational strategies may be insufficient to alter patient behavior and improve management of hyperphosphatemia.
• Further research is needed to identify more effective interventions for managing hyperphosphatemia and its associated complications.